Evidence map›Paper›PMID 26693331›Full record

ReviewEcho research and practice2015

Diagnosis and management of hypertrophic cardiomyopathy.

Antonis Pantazis, Annina S Vischer, Maria Carrillo Perez-Tome, Silvia Castelletti

Open access · goldAbstract readReview
In one paragraph

Review in Echo research and practice, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
5.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 52 citations in OpenAlex.

  1. Surgical management of hypertrophic cardiomyopathy.Indian journal of thoracic and cardiovascular surgery · 2026
    Review
  2. Article
  3. Obstructive hypertrophic cardiomyopathy: from genetic insights to a multimodal therapeutic approach with mavacamten, aficamten, and beyond.The Egyptian heart journal : (EHJ) : official bulletin of the Egyptian Society of Cardiology · 2024
    Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Cardiomyopathies and Related Changes in Contractility of Human Heart Muscle.International journal of molecular sciences · 2018
    Review
  12. Article
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Antonis PantazisThe Heart Hospital , 16-18 Westmoreland Street, London, W1G 8PH , UK.
Annina S VischerThe Heart Hospital , 16-18 Westmoreland Street, London, W1G 8PH , UK.
Maria Carrillo Perez-TomeThe Heart Hospital , 16-18 Westmoreland Street, London, W1G 8PH , UK.
Silvia CastellettiThe Heart Hospital , 16-18 Westmoreland Street, London, W1G 8PH , UK.
University College Hospital at Westmoreland Street · GBUniversity College London · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The clinical spectrum of hypertrophic cardiomyopathy (HCM) is complex and includes a variety of phenotypes, which leads to different types of manifestations. Although most of the patients are asymptomatic, a significant proportion of them will develop symptoms or risk of arrhythmias and sudden cardiac death (SCD). Therefore, the objectives of HCM diagnosis and management are to relieve the patients' symptoms (chest pain, heart failure, syncope, palpitations, etc.), prevent disease progression and major cardiovascular complications and SCD. The heterogeneity of HCM patterns, their symptoms and assessment is a challenge for the cardiologist.

Indexed as

amyloidosisAnderson-Fabry's diseasecardiac magnetic resonance imagingFriedreich's ataxiahypertrophic cardiomyopathyleft ventricular outflow tract obstruction

Identifiers

PMID26693331
PMCPMC4676455
OpenAlexW2113780296

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.